Intravascular optical coherence tomography (OCT) is an imaging modality uniquely characterized by its high resolution. OCT can visualize in vivo plaque characteristics and detect vulnerable plaque, such as thin-cap fibroatheroma, which has a large lipid pool with overlying thin fibrous cap. OCT can also help the clinicians to identify the underlying pathology of acute coronary syndrome: plaque rupture, plaque erosion, and calcified nodule. The OCT system enables automated measurement of the lumen diameter, lumen area, and lesion length, which is useful to determine appropriate reference sites, stent size and stent length during percutaneous coronary intervention (PCI). Evaluation of underlying plaque characteristics is helpful in predicting possible complications after PCI. OCT-guided PCI may acquire comparable angiographical and clinical outcomes to intravascular ultrasound-guided PCI. OCT can be used to evaluate characteristics of non-culprit plaque and efficacy of lipidlowering therapy on plaque stabilization. OCT also clearly visualizes mechanical vessel injury after stent implantation. Notably, the presence of irregular tissue protrusion has been shown to be associated with the occurrence of device-oriented clinical events. Recent studies suggest that OCT is feasible for the selection of conservative management without stenting in patients with acute coronary syndrome caused by plaque erosion.
Introduction
It has been 40 years since the first balloon coronary angioplasty procedure was performed.
1) Since then, development of treatment devices such as bare metal stents, 2) drug-eluting stents, 3) and bioresorbable vascular scaffolds 4) has dramatically changed the management of patients with coronary artery disease. Intracoronary imaging modalities such as intravascular ultrasound 
In Vivo Plaque Characterization
The strength of OCT imaging is its high resolution (10-20 μm), 17) which has enabled visualization of coronary artery structures and plaque characteristics such as fibrous, fibrocalcific, and lipid-rich plaques ( Fig. 1) , 15) and established the measurement of OCT has also allowed in vivo diagnosis of plaque erosion ( OCT-derived calcified nodule (Fig. 2C) certain whether repeated spasm may cause plaque erosion or vice versa.
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OCT Guidance for PCI
OCT system enables automated measurement of the lumen diameter and lumen area in each cross-sectional frame, and lesion length by the longitudinal view. These measurements are useful to determine appropriate reference sites, stent size, and stent length during PCI. The presence of lipidic plaque and fibrocalcific plaque at the stent edge is associated with the higher incidence of stent edge dissection than fibrous plaques. 41, 42) The presence of lipidic plaque at the stent edge is also reportedly associated with post-PCI myocardial infarction 43) and stent edge restenosis. 44) Therefore, selecting healthy landing zones is preferred for optimal stent deployment.
45)
The evaluation of underlying plaque characteristics is also important to predict worse outcomes after PCI. The presence of OCT-derived TCFA is associated with the occurrence of no-reflow phenomenon, 46) post-PCI myocardial injury/infarction, [47] [48] [49] and microvascular obstruction on cardiac magnetic resonance imaging. 50) Greater amount of residual thrombus burden after aspiration thrombectomy is related to worse microvascular dysfunction and greater post-PCI myocardial injury.
51)
Usefulness of OCT guidance for PCI has been evaluated in several studies. In the retrospective CLI-OPCI study, OCTguided PCI was associated with a significantly lower one-year risk of the composite of cardiac death, myocardial infarction, or repeat revascularization compared to angiography-guided PCI. 52) In the ILUMIEN I study, PCI optimization based on pre-PCI and post-PCI OCT was associated with reduced rates of post-PCI myocardial infarction. 53) The ILUMIEN II study reported OCT guidance was associated with comparable stent expansion to IVUS guidance. 54) The DOCTORS study demonstrated that OCT-guided PCI was associated with higher post-PCI fractional flow reserve than angiography-guided PCI. 55) The OPIN-ION trial demonstrated non-inferiority of optical frequency-domain imaging-guided PCI compared to IVUS-guided PCI with regard to the incidence of target vessel failure for 1 year 56) and the acquisition of comparable minimal lumen area at 8-month follow-up OCT. 57) The ILUMIEN III: OPTIMIZE PCI study was the first randomized controlled trial that compared OCT-guided, IVUS-guided, and angiography-guided PCI. In this study, OCT guidance showed similar angiographical and clinical outcomes, and non-inferiority in achieving similar minimal stent area, compared to IVUS guidance. 58) Larger randomized controlled trials are warranted to evaluate whether OCT-guided PCI yields superior outcomes to IVUS-guided or angiography-guided PCI.
Evaluation of Non-culprit Plaque Characteristics
OCT has an advantage in evaluating the characteristics in non-culprit plaques. The greater vulnerability in non-culprit plaques is observed in patients with ACS, 59 ) diabetes mellitus, 60, 61) and chronic kidney disease. 62) A recent study showed that the presence of non-culprit lipid-rich plaque in PCI-treated vessels was associated with non-culprit lesion-related future events. 63) These studies suggest that OCT can identify patients at high risk in the future. and tissue protrusion 70, 71) in higher frequency compared to IVUS. 72, 73) OCT is capable of detecting smaller stent edge dissection (Fig. 3A) than IVUS, 74) but OCT-detected stent edge dissection is not associated with the clinical events. [73] [74] [75] [76] [77] Incomplete stent apposition (Fig. 3B ) may be related to persistent malapposition, 75) or delayed neointimal coverage, 78) but small incomplete stent apposition is not related to clinical events. [73] [74] [75] [76] 79) Tissue protrusion (Fig. 3C ) may be related to neointimal hyperplasia, 80) but does not affect the occurrence of clinical events either. [72] [73] [74] [75] [76] [80] [81] [82] Notably, the presence of irregular tissue protrusion, which suggests deep vessel injury and underlying large lipid components, has been shown to be associated with the occurrence of device-oriented clinical events for 1 year. 76, 83) So far, the way to prevent the incidence of irregular tissue protrusion or to treat irregular protrusion after PCI remains undetermined.
Tailored Management in Patients with Plaque Erosion
Currently, patients with ACS have been uniformly treated with stent implantation. 84, 85) Recent studies suggest that conservative management without stenting may be an option in patients with ACS caused by plaque erosion. 86, 87) OCT is the only intracoronary imaging device that can visualize plaque erosion owing to its high resolution. The EROSION study has shown the feasibility and safety of anti-thrombotic therapy without stenting in patients with ACS caused by plaque erosion. 86) The use of OCT may bring a major shift in the management away from routine stenting toward more tailored management in patients with plaque erosion. 
Limitations and Future Directions of OCT
